Year 2020 / Volume 27 / Number 1

Abstract PDF HTML

Cilinical Note

Effectiveness of the association of lacosamide in trigeminal neuralgia

Rev. Soc. Esp. Dolor. 2020; 27(1): 50-52 / DOI: 10.20986/resed.2019.3738/2019

Abel Alejandro Sanabria Sanchinel, María de los Angeles Livengood Ordóñez


ABSTRACT

Trigeminal neuralgia is a frequent reason for consultation in neurology, it is highly complex and incapacitating. Its approach, in addition to an adequate etiological focusing, requires effective symptomatic treatment. We present two patients with trigeminal neuralgia and good response to treatment with lacosamide. Lacosamide is a drug that appears to be a safe and effective alternative in the treatment of neuropathic pain.



RESUMEN

La neuralgia del trigémino es un motivo de consulta frecuente en neurología, es sumamente complejo e incapacitante. Su abordaje, además de un adecuado enfoque etiológico, precisa de un tratamiento sintomático eficaz. Presentamos dos pacientes con neuralgia del trigémino y buena respuesta al tratamiento con lacosamida. La lacosamida es un fármaco que muestra ser una alternativa segura y eficaz en el tratamiento del dolor neuropático.





Complete Article

Nuevo comentario

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comentarios

No comments in this article

Bibliografía

1. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: IASP Press; 1994. p. 59-71.
2. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and Clinical Features of Idiopathic Trigeminal Neuralgia and Glossopharyngeal Neuralgia: Similarities and Differences. Rochester, Minnesota 1945-1984. Neuroepidemiology. 1991;10(5-6):276-81.
DOI: 10.1159/000110284
3. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3.rd edition. Cephalalgia. 2018;38(1):1-211.
DOI: 10.1177/0333102417738202
4. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice Parameter: the Diagnostic Evaluation and Treatment of Trigeminal Neuralgia (an Evidence-based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183-90.
DOI: 10.1212/01.wnl.0000326598.83183.04
5. Bermejo PE, Alba-Alcantara L. Efficacy of Lacosamide in the Treatment of Neuropathic Pain. Rev Neurol 2013;56(3):188-90.
6. Gómez-Argüelles JM, Bermejo PE, Lara M, Almajano J, Aragón E, García del Carrizo F, et al. Effectiveness of Lacosamide in the Treatment of Refractory Neuropathic Pain: an Open Observational Trial. Rev Neurol 2014;59(7):289-93.
7. García-Escrivá A, López-Hernández N, Gil-Cortés C. Treatment of Neuropathic Pain with Lacosamide. Rev Neurol. 2012;54(3):167-72.
8. Marín-Gracia M, Cantero-Lozano D, Garcés-Antón E, López-Bravo A, Garrido-Fernández A, Navarro-Pérez MP, et al. Lacosamide Associated with High-degree Block in a Patient with Trigeminal Neuralgia. Rev Neurol 2018;66(6):189-92.
9. Pozo-Rosich P, Jiménez D, Rey A, Sánchez-Ojanguren J, Viguera-Romero J. Neuropatías craneales dolorosas y otros dolores faciales. Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología, eds. Guía oficial de práctica clínica en cefaleas. Madrid: SEN/Luzán 5; 2015.
10. McCleane G. Lacosamide for Pain. Expert Opin Investig Drugs. 2010;19(9):1129-34.
DOI: 10.1517/13543784.2010.511174
11. Krause LU, Brodowski KO, Kellinghaus C. Atrioventricular Block Following Lacosamide Intoxication. Epilepsy Behav. 2011;20(4):725-7.
DOI: 10.1016/j.yebeh.2011.02.006
12. Nizam A, Mylavarapu K, Thomas D, Briskin K, Wu B, Saluja D, et al. Lacosamide-induced Second-degree Atrioventricular Block in Patient with Partial Epilepsy. Epilepsia. 2011;52(10):153-5.
DOI: 10.1111/j.1528-1167.2011.03212.x

Artículos relacionados

Continuous electrical stimulation for the treatment of trigeminal neuralgia. A systematic review

Rev. Soc. Esp. Dolor. 2023; 30(4): 217-226 / DOI: 10.20986/resed.2023.4043/2022

Persistent headache after craniotomy for meningioma: charting of the afferent pathways for nociception: a discussion

Rev. Soc. Esp. Dolor. 2023; 30(3): 191-195 / DOI: 10.20986/resed.2023.4069/2023

Use of 8 % capsaicin patches for the treatment of lumbar neuropathic pain

Rev. Soc. Esp. Dolor. 2022; 29(1): 28-33 / DOI: 10.20986/resed.2022.3995/2022

Observational and prospective study on the effectiveness and safety of the dorsal root ganglion stimulation in patients with refractory neuropathic pain

Rev. Soc. Esp. Dolor. 2021; 28(2): 148-156 / DOI: 10.20986/resed.2021.3879/2020

Analgesic effectiveness of tapentadol in neuropathic pain secondary to post-laminectomy syndrome

Rev. Soc. Esp. Dolor. 2021; 28(2): 71-75 / DOI: 10.20986/resed.2021.3822/2020

Efficacy of lidocaine perfusions in fibromyalgia: a prospective cohort study

Rev. Soc. Esp. Dolor. 2020; 27(5): 287-291 / DOI: 10.20986/resed.2020.3796/2020

Clinical pathophysiology in patients with sickle cell disease: the transition from acute to chronic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 257-268 / DOI: 10.20986/resed.2020.3814/2020

Efficacy of pregabalin, gabapentin and duloxetine in neuropathic pain verified by the p-curve analysis

Rev. Soc. Esp. Dolor. 2020; 27(1): 16-23 / DOI: 10.20986/resed.2020.3727/2019

Dysphonia as side-effect dose-dependent during treatment with duloxetine

Rev. Soc. Esp. Dolor. 2018; 25(6): 359-359 / DOI: 10.20986/resed.2017.3528/2016

Evidence-based recommendations for the management of neuropathic pain (review of the literature)

Rev. Soc. Esp. Dolor. 2018; 25(6): 349-358 / DOI: 10.20986/resed.2018.3673/2018

Changes in intraocular pressure in patients with trigeminal neuralgia subject to radio frequency of the Gasserian ganglion

Rev. Soc. Esp. Dolor. 2018; 25(6): 342-348 / DOI: 10.20986/resed.2018.3657/2018

Platelet-rich plasma in treating peripheral neuropathic pain. Preliminary report

Rev. Soc. Esp. Dolor. 2018; 25(5): 263-270 / DOI: 10.20986/resed.2017.3625/2017

Instrucciones para citar

Sanabria Sanchinel A, Livengood Ordóñez M. Effectiveness of the association of lacosamide in trigeminal neuralgia. Rev Soc Esp Dolor 2020; 27(1): 50-52 / DOI: 1020986/resed20193738/2019


Descargar a un gestores de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 31645 veces.
Este artículo ha sido descargado 13 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 20/04/2019

Aceptado: 08/07/2019

Prepublicado: 16/10/2019

Publicado: 19/02/2020

Tiempo de revisión del artículo: 70 días

Tiempo de prepublicación: 179 días

Tiempo de edición del artículo: 305 días


Compartir

Este artículo aun no tiene valoraciones.
Reader rating:
Rate this article:
Send by e-mail
© 2024 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexada en:
Política de Privacidad